PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

Čájet eará veršuvnnaid (1)
Bibliográfalaš dieđut
Váldodahkkit: Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P
Materiálatiipa: Conference item
Almmustuhtton: 2009
Govvádus
Čoahkkáigeassu:

Geahča maid